NCT06745115 Detection of Sepsis Occurrence by Using Blood Fluorescence
| NCT ID | NCT06745115 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhujiang Hospital |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2023-09-09 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2023-09-09 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study adopted a case-control study method to explore a reagent-free, highly sensitive, and frequently screened blood fluorescence metabolite analyzer for sepsis, which can detect the emergence of inflammatory free radicals before organ damage and shorten the diagnosis time of sepsis.
Eligibility Criteria
Inclusion Criteria: 1. Healthy control group: Individuals who are physically healthy with no underlying diseases and have not been hospitalized within the past two years. Recruitment for healthy volunteers will be conducted through notices and online media. 2. Sepsis Experimental Group: Patients with confirmed infections, having qSOFA ≥ 2 and SOFA ≥ 2, will be screened and confirmed by a physician to meet the inclusion criteria. 3. Non-septic Severe Control Group: Patients with suspected or confirmed infections, having a SOFA score of 1, will be screened and confirmed by a physician to meet the inclusion criteria. Exclusion Criteria: minors, pregnant, individuals with mental illnesses, and other vulnerable groups.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06745115 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06745115 currently recruiting?
Yes, NCT06745115 is actively recruiting participants. Contact the research team at chen_ning16@foxmail.com for enrollment information.
Where is the NCT06745115 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06745115 clinical trial?
NCT06745115 is sponsored by Zhujiang Hospital. The trial plans to enroll 90 participants.